drugset / Trial / NCT02611245

NIR Fluorescence Imaging Technique in Thoracic Surgery With ICG

NCT02611245

NaSingle-groupOpen-labelTreatment

Summary

This study aims to first apply near-infrared fluorescence imaging technology in thoracic surgery with indocyanine green in China. To evaluate the feasibility usage of the investigators' fluorescence imaging systems and the safety applications in intraoperative sentinel lymph node mapping of lung and esophageal cancer, lung nodule imaging, lung segment resection boundary determination, esophagus - tubular anastomosis, thoracic duct imaging and chylothorax repairing thoracic surgery. Aim to achieve precise boundaries definition during thoracic surgery and realize accurate, minimally invasive thoracic surgery with fluorescence imaging technology.

Timeline

Start
2015-08
Primary completion
2016-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 0.5 mg/kg Intravenous
Subject Indocyanine Green Diagnostic / imaging agent 5 mg/kg Intravenous
Subject Indocyanine Green Diagnostic / imaging agent 10 mg Intravenous